Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
It's not possible to invest over long periods without making some bad investments. But you want to avoid the really...
Alkermes (ALKS) beats earnings and sales estimates for the first quarter of 2020. The company withdraws its previously provided outlook for 2020 amid uncertainty related to coronavirus.
Alkermes (ALKS) beats earnings and sales estimates for the first quarter of 2020. The company withdraws its previously provided outlook for 2020 amid uncertainty related to coronavirus.
Alkermes price target lowered to $23 from $25 at H.C. Wainwright H.C. Wainwright ALKS
Analysts fell to the sidelines weighing in on Vertex Pharmaceuticals (VRTX), United Therapeutics (UTHR) and Alkermes (ALKS) with neutral ratings,

108 Biggest Movers From Yesterday

09:30am, Thursday, 30'th Apr 2020
Gainers Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares jumped 252.7% to close at $8.50 on Wednesday after the company reported that its new data from study of 6 critically-ill...
Alkermes Plc (NASDAQ:ALKS)’s stock price was down 10.6% during mid-day trading on Wednesday after Piper Sandler lowered their price target on the stock from $22.00 to $21.00. Piper Sandler currently
Q1 2020 Alkermes Plc Earnings Call
ALKS earnings call for the period ending March 31, 2020.
Alkermes plc (NASDAQ:ALKS) Q1 2020 Results Earnings Conference Call April 29, 2020, 08:00 AM ET Company Participants Sandra Coombs - Vice President, Investor Re
Alkermes price target lowered to $17 from $20 at Stifel Stifel ALKS
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE